3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Whooping Cough
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Measles
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Interventions
Cyclophosphamide
16
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
13
Whole-Body Irradiation
10
Cyclosporine
10
Antilymphocyte Serum
9
Melphalan
8
Busulfan
8
Mycophenolic Acid
7
Filgrastim
6
fludarabine
5
Radiotherapy
5
Methotrexate
5
Etoposide
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cytarabine
4
Carmustine
4
Blood Specimen Collection
4
thymoglobulin
3
Therapeutics
3
Rituximab
3
Flow Cytometry
3
Aprepitant
3
Analgesia
3
Tacrolimus
2
Stem Cell Transplantation
2
Proton Therapy
2
Polymerase Chain Reaction
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hodgkin Disease
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts